Strikingly, we found that introduction of BRAF p.V600E hotspot mutation in HNSCC cell model, FaDu, strongly inhibited p-ErbB3(Y1289) expression versus control (∼77.8% inhibition, P = 0.0038, Fig 2B). The gene discussed is ERBB3; the disease is head and neck squamous cell carcinoma.